Updated ACIP recommendations for varicella immunisation Newsletter Article 18 February 2013 Pages: 3 - 3
UK debate over interferon-β prescribing continues Tracey Wright Newsletter Article 18 February 2013 Pages: 5 - 6
Antiretrovirals cost effective in preventing vertical HIV transmission Newsletter Article 18 February 2013 Pages: 7 - 7
Meningococcal group C conjugate vaccine immunogenic in infants Newsletter Article 18 February 2013 Pages: 8 - 8
Shigella conjugate vaccines are promising in children Newsletter Article 18 February 2013 Pages: 8 - 8
The case for mitoxantrone in multiple sclerosis Jo Dalton Newsletter Article 18 February 2013 Pages: 9 - 10
Carboplatin casts cisplatin off the ovarian cancer stage Carmen Innes Newsletter Article 18 February 2013 Pages: 13 - 14
Longer survival duration in breast cancer with docetaxel Newsletter Article 18 February 2013 Pages: 17 - 17
Should adjuvant chemotherapy be used in B2 colon cancer? Newsletter Article 18 February 2013 Pages: 18 - 18
No valvular regurgitation after stopping dexfenfluramine Newsletter Article 18 February 2013 Pages: 20 - 20
Troglitazone prescribing information updated in the US Newsletter Article 18 February 2013 Pages: 20 - 20
Guidelines for dexfenfluramine/fenfluramine users issued in NZ Newsletter Article 18 February 2013 Pages: 21 - 21
Media raises concern over MMR vaccine and bowel disease Newsletter Article 18 February 2013 Pages: 21 - 21
New chemical entities recommended for approval in Japan Newsletter Article 18 February 2013 Pages: 22 - 22